Evidence map›Paper›PMID 26715309›Full record

ArticleBMC structural biology2015

The crystal structure of the Hazara virus nucleocapsid protein.

Rebecca Surtees, Antonio Ariza, Emma K Punch, Chi H Trinh, Stuart D Dowall, Roger Hewson, Julian A Hiscox, John N Barr, Thomas A Edwards

Open access · hybridAbstract read
In one paragraph

Article in BMC structural biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Effects ofViruses · 2025
    Article
  4. Article
  5. Article
  6. The Phlebovirus Ribonucleoprotein: An Overview.Methods in molecular biology (Clifton, N.J.) · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Cranberry (Pathogens (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rebecca SurteesPublic Health England, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK. bs06ras@leeds.ac.uk.
Antonio ArizaSchool of Molecular and Cellular Biology, Faculty of Biological Sciences, and Astbury Centre for Molecular and Structural Biology, University of Leeds, Leeds, LS2 9JT, UK. antonio.ariza@path.ox.ac.uk.
Emma K PunchSchool of Molecular and Cellular Biology, Faculty of Biological Sciences, and Astbury Centre for Molecular and Structural Biology, University of Leeds, Leeds, LS2 9JT, UK. bsekp@leeds.ac.uk.
Chi H TrinhSchool of Molecular and Cellular Biology, Faculty of Biological Sciences, and Astbury Centre for Molecular and Structural Biology, University of Leeds, Leeds, LS2 9JT, UK. C.H.Trinh@leeds.ac.uk.
Stuart D DowallPublic Health England, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK. Stuart.Dowall@phe.gov.uk.
Roger HewsonPublic Health England, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK. Roger.Hewson@phe.gov.uk.
Julian A HiscoxSchool of Molecular and Cellular Biology, Faculty of Biological Sciences, and Astbury Centre for Molecular and Structural Biology, University of Leeds, Leeds, LS2 9JT, UK. Julian.Hiscox@liverpool.ac.uk.
John N BarrSchool of Molecular and Cellular Biology, Faculty of Biological Sciences, and Astbury Centre for Molecular and Structural Biology, University of Leeds, Leeds, LS2 9JT, UK. j.n.barr@leeds.ac.uk.
Thomas A EdwardsSchool of Molecular and Cellular Biology, Faculty of Biological Sciences, and Astbury Centre for Molecular and Structural Biology, University of Leeds, Leeds, LS2 9JT, UK. t.a.edwards@leeds.ac.uk.
University of Leeds · GBPublic Health England · GBInstitute of Structural and Molecular Biology · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F016603/1Biotechnology and Biological Sciences Research Council BB/L015056/1Wellcome TrustWellcome Trust 094232
6 · The paper itself

Abstract

backgroundHazara virus (HAZV) is a member of the Bunyaviridae family of segmented negative stranded RNA viruses, and shares the same serogroup as Crimean-Congo haemorrhagic fever virus (CCHFV). CCHFV is responsible for fatal human disease with a mortality rate approaching 30 %, which has an increased recent incidence within southern Europe. There are no preventative or therapeutic treatments for CCHFV-mediated disease, and thus CCHFV is classified as a hazard group 4 pathogen. In contrast HAZV is not associated with serious human disease, although infection of interferon receptor knockout mice with either CCHFV or HAZV results in similar disease progression. To characterise further similarities between HAZV and CCHFV, and support the use of HAZV as a model for CCHFV infection, we investigated the structure of the HAZV nucleocapsid protein (N) and compared it to CCHFV N. N performs an essential role in the viral life cycle by encapsidating the viral RNA genome, and thus, N represents a potential therapeutic target.

resultsWe present the purification, crystallisation and crystal structure of HAZV N at 2.7 Å resolution. HAZV N was expressed as an N-terminal glutathione S-transferase (GST) fusion protein then purified using glutathione affinity chromatography followed by ion-exchange chromatography. HAZV N crystallised in the P212121 space group with unit cell parameters a = 64.99, b = 76.10, and c = 449.28 Å. HAZV N consists of a globular domain formed mostly of alpha helices derived from both the N- and C-termini, and an arm domain comprising two long alpha helices. HAZV N has a similar overall structure to CCHFV N, with their globular domains superposing with an RMSD = 0.70 Å, over 368 alpha carbons that share 59 % sequence identity. Four HAZV N monomers crystallised in the asymmetric unit, and their head-to-tail assembly reveals a potential interaction site between monomers.

conclusionsThe crystal structure of HAZV N reveals a close similarity to CCHFV N, supporting the use of HAZV as a model for CCHFV. Structural similarity between the N proteins should facilitate study of the CCHFV and HAZV replication cycles without the necessity of working under containment level 4 (CL-4) conditions.

Indexed as

NairovirusAmino Acid SequenceCrystallography, X-RayHumansModels, MolecularMolecular Sequence DataNucleocapsid ProteinsProtein Structure, SecondaryStatic ElectricityNucleocapsid Proteins

Identifiers

PMID26715309
PMCPMC4696240
OpenAlexW2204843529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.